0.16Open0.11Pre Close15 Volume733 Open Interest0.50Strike Price235.00Turnover213.85%IV14.22%PremiumAug 16, 2024Expiry Date0.09Intrinsic Value100Multiplier24DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type-0.5337Delta1.7641Gamma2.72Leverage Ratio-0.0018Theta-0.0002Rho-1.45Eff Leverage0.0004Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet